Back To Rising Leaders Gallery
In her role as INOVIO Pharmaceuticals, Inc.’s senior vice president of research and development, Kate Broderick, an accomplished scientist...
Setting Ego Aside To Better Human Health
Interview With INOVIO's Kate Broderick
Listen to this article
Kate Broderick, SVP of research and development at INOVIO and one of In Vivo’s 2021 rising leaders, is hopeful that greater collaboration will be the lasting effect of COVID-19.
Candid conversations with C-suite leaders.
More from C-Suite Speaks
BMS has launched a new cancer drug access program for low-to-middle income countries, focusing on addressing health inequities and widening accessibility.
• By
Exec summary XXXXXXX
More from Leadership
• By
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.
• By
The seventh annual edition of In Vivo’s Rising Leaders features entrepreneurs, academics, lawyers, regulators and innovators from around the globe, representing the forefront of creativity in health care.
• By
The seventh annual edition of In Vivo’s Rising Leaders features entrepreneurs, academics, lawyers, regulators and innovators from around the globe, representing the forefront of creativity in health care.